When Do Generics Challenge Drug Patents?
Author
Abstract
Suggested Citation
DOI: 10.1111/j.1740-1461.2011.01235.x
Download full text from publisher
References listed on IDEAS
- Hegde, Deepak & Sampat, Bhaven, 2009. "Examiner citations, applicant citations, and the private value of patents," Economics Letters, Elsevier, vol. 105(3), pages 287-289, December.
- Adam B. Jaffe & Josh Lerner, 2006.
"Innovation and its Discontents,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 6, pages 27-66,
National Bureau of Economic Research, Inc.
- Jaffe Adam B. & Lerner Josh, 2006. "Innovation and Its Discontents," Capitalism and Society, De Gruyter, vol. 1(3), pages 1-36, December.
- Bhaven N. Sampat, 2010. "When Do Applicants Search for Prior Art?," Journal of Law and Economics, University of Chicago Press, vol. 53(2), pages 399-416, May.
- G. M.P. Swann, 2009. "The Economics of Innovation," Books, Edward Elgar Publishing, number 13211.
- Fiona M. Scott Morton, 1999. "Entry Decisions in the Generic Pharmaceutical Industry," RAND Journal of Economics, The RAND Corporation, vol. 30(3), pages 421-440, Autumn.
- Henry G. Grabowski & Margaret Kyle, 2007. "Generic competition and market exclusivity periods in pharmaceuticals," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 491-502.
- Jeremy Bulow, 2004. "The Gaming of Pharmaceutical Patents," NBER Chapters, in: Innovation Policy and the Economy, Volume 4, pages 145-187, National Bureau of Economic Research, Inc.
- Lanjouw, Jean O & Pakes, Ariel & Putnam, Jonathan, 1998.
"How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data,"
Journal of Industrial Economics,
Wiley Blackwell, vol. 46(4), pages 405-432, December.
- Jean O. Lanjouw & Ariel Pakes & Jonathan Putnam, 1996. "How to Count Patents and Value Intellectual Property: Uses of Patent Renewal and Application Data," NBER Working Papers 5741, National Bureau of Economic Research, Inc.
- Frank R. Lichtenberg & Suchin Virabhak, 2007.
"Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health',"
Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 371-392.
- Frank R. Lichtenberg & Suchin Virabhak, 2002. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"," NBER Working Papers 9351, National Bureau of Economic Research, Inc.
- Wesley M. Cohen & Richard R. Nelson & John P. Walsh, 2000.
"Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not),"
NBER Working Papers
7552, National Bureau of Economic Research, Inc.
- Wesley M Cohen & Richard R Nelson & John P Walsh, 2003. "Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (Or Not)," Levine's Working Paper Archive 618897000000000624, David K. Levine.
- Fiona M. Scott Morton, 1999. "Entry Decisions in the Generic Pharmaceutical Industry," Yale School of Management Working Papers ysm119, Yale School of Management.
- Frank Lichtenberg, 2009. "The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 407-428.
- Filson, Darren & Oweis, Ahmed, 2010. "The impacts of the rise of Paragraph IV challenges on startup alliance formation and firm value in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 29(4), pages 575-584, July.
- Jean O. Lanjouw & Ariel Pakes & Jonathan Putnam, 1998.
"How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data,"
Journal of Industrial Economics, Wiley Blackwell, vol. 46(4), pages 405-432, December.
- Jean O. Lanjouw & Ariel Pakes & Jonathan Putnam, 1996. "How to Count Patents and Value Intellectual Property: Uses of Patent Renewal and Application Data," NBER Working Papers 5741, National Bureau of Economic Research, Inc.
- James Bessen & Michael J. Meurer, 2008. "Introduction to Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk," Introductory Chapters, in: Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk, Princeton University Press.
- David Reiffen & Michael R. Ward, 2005. "Generic Drug Industry Dynamics," The Review of Economics and Statistics, MIT Press, vol. 87(1), pages 37-49, February.
- Richard C. Levin & Alvin K. Klevorick & Richard R. Nelson & Sidney G. Winter, 1987. "Appropriating the Returns from Industrial Research and Development," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 18(3, Specia), pages 783-832.
- Jean O. Lanjouw & Mark Schankerman, 2004. "Patent Quality and Research Productivity: Measuring Innovation with Multiple Indicators," Economic Journal, Royal Economic Society, vol. 114(495), pages 441-465, April.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
- Durvasula, Maya & Hemphill, C. Scott & Ouellette, Lisa Larrimore & Sampat, Bhaven & Williams, Heidi L., 2023.
"The NBER Orange Book Dataset: A user’s guide,"
Research Policy, Elsevier, vol. 52(7).
- Maya Durvasula & C. Scott Hemphill & Lisa Larrimore Ouellette & Bhaven N. Sampat & Heidi L. Williams, 2022. "The NBER Orange Book Dataset: A User’s Guide," NBER Working Papers 30628, National Bureau of Economic Research, Inc.
- Wagner, Stefan & Sternitzke, Christian & Walter, Sascha, 2022.
"Mapping Markush,"
Research Policy, Elsevier, vol. 51(10).
- Stefan Wagner & Christian Sternitzke & Sascha Walter, 2022. "Mapping Markush," ESMT Research Working Papers ESMT-22-05, ESMT European School of Management and Technology.
- Matthew J. Higgins & Mathias J. Kronlund & Ji Min Park & Joshua Pollet, 2020. "The Role of Assets In Place: Loss of Market Exclusivity and Investment," NBER Working Papers 27588, National Bureau of Economic Research, Inc.
- C. Scott Hemphill & Bhaven N. Sampat, 2012. "Weak Patents Are a Weak Deterrent: Patent Portfolios, the Orange Book Listing Standard, and Generic Entry in Pharmaceuticals," NBER Chapters, in: Standards, Patents and Innovations, National Bureau of Economic Research, Inc.
- Sampat, Bhaven N. & Shadlen, Kenneth C., 2017.
"Secondary pharmaceutical patenting: A global perspective,"
Research Policy, Elsevier, vol. 46(3), pages 693-707.
- Bhaven N. Sampat & Kenneth C. Shadlen, 2017. "Secondary Pharmaceutical Patenting: A Global Perspective," NBER Working Papers 23114, National Bureau of Economic Research, Inc.
- Javad Moradpour & Aidan Hollis, 2021. "The economic theory of cost‐effectiveness thresholds in health: Domestic and international implications," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1139-1151, May.
- Shamim S. Mondal & Viswanath Pingali, 2017. "Competition and Intellectual Property Policies in the Indian Pharmaceutical Sector," Vikalpa: The Journal for Decision Makers, , vol. 42(2), pages 61-79, June.
- Amy Kapczynski & Chan Park & Bhaven Sampat, 2012. "Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-9, December.
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
- Bhaven N. Sampat, 2015. "Intellectual property rights and pharmaceuticals: The case of antibiotics," WIPO Economic Research Working Papers 26, World Intellectual Property Organization - Economics and Statistics Division.
- Hemphill, C. Scott & Sampat, Bhaven N., 2012. "Evergreening, patent challenges, and effective market life in pharmaceuticals," Journal of Health Economics, Elsevier, vol. 31(2), pages 327-339.
- Mondal, Shamim S. & Pingali, Viswanath, 2015. "Competition Law and the Pharmaceutical Sector in India," IIMA Working Papers WP2015-11-02, Indian Institute of Management Ahmedabad, Research and Publication Department.
- Beall, Reed F. & Hardcastle, Lorian & Clement, Fiona & Hollis, Aidan, 2019. "How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?," Health Policy, Elsevier, vol. 123(12), pages 1251-1258.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Antoine Dechezleprêtre & Yann Ménière & Myra Mohnen, 2017.
"International patent families: from application strategies to statistical indicators,"
Scientometrics, Springer;Akadémiai Kiadó, vol. 111(2), pages 793-828, May.
- Antoine Dechezleprêtre & Yann Ménière & Myra Mohnen, 2017. "International patent families: from application strategies to statistical indicators," Post-Print hal-01693881, HAL.
- Antoine Dechezleprêtre & Yann Ménière & Myra Mohnen, 2017. "International patent families: from application strategies to statistical indicators," GRI Working Papers 264, Grantham Research Institute on Climate Change and the Environment.
- Dechezleprêtre, Antoine & Ménière, Yann & Mohnen, Myra, 2017. "International patent families: from application strategies to statistical indicators," LSE Research Online Documents on Economics 69486, London School of Economics and Political Science, LSE Library.
- Gaétan de Rassenfosse & Adam B. Jaffe, 2018.
"Are patent fees effective at weeding out low‐quality patents?,"
Journal of Economics & Management Strategy, Wiley Blackwell, vol. 27(1), pages 134-148, March.
- Gaétan de Rassenfosse & Adam B. Jaffe, 2014. "Are Patent Fees Effective at Weeding out Low-quality Patents?," NBER Working Papers 20785, National Bureau of Economic Research, Inc.
- Gaétan de Rassenfosse & Adam B. Jaffe, 2015. "Are Patent Fees Effective at Weeding Out Low-Quality Patents?," Working Papers 15_01, Motu Economic and Public Policy Research.
- C. Scott Hemphill & Bhaven N. Sampat, 2012. "Weak Patents Are a Weak Deterrent: Patent Portfolios, the Orange Book Listing Standard, and Generic Entry in Pharmaceuticals," NBER Chapters, in: Standards, Patents and Innovations, National Bureau of Economic Research, Inc.
- Fischer, Timo & Henkel, Joachim, 2012. "Patent trolls on markets for technology – An empirical analysis of NPEs’ patent acquisitions," Research Policy, Elsevier, vol. 41(9), pages 1519-1533.
- Mohd Shadab Danish & Pritam Ranjan & Ruchi Sharma, 2021. "Identification of “Valuable” Technologies via Patent Statistics in India: An Analysis Based on Renewal Information," BASE University Working Papers 13/2021, BASE University, Bengaluru, India.
- Mark A. Lemley & Carl Shapiro, 2005.
"Probabilistic Patents,"
Journal of Economic Perspectives, American Economic Association, vol. 19(2), pages 75-98, Spring.
- Lemley, Mark A. & Shapiro, Carl, 2004. "Probabilistic Patents," Competition Policy Center, Working Paper Series qt9xf1488p, Competition Policy Center, Institute for Business and Economic Research, UC Berkeley.
- Bronwyn Hall & Christian Helmers & Mark Rogers & Vania Sena, 2014.
"The Choice between Formal and Informal Intellectual Property: A Review,"
Journal of Economic Literature, American Economic Association, vol. 52(2), pages 375-423, June.
- Hall, Bronwyn & Helmers, Christian & Rogers, Mark & Sena, Vania, 2014. "The Choice between Formal and Informal Intellectual Property: A Review," Department of Economics, Working Paper Series qt4271z78q, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
- Magazzini Laura & Fabio Pammolli & Massimo Riccaboni, 2013. "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers 3/2013, IMT School for Advanced Studies Lucca, revised Jul 2013.
- Justus Baron & Henry Delcamp, 2012. "The private and social value of patents in discrete and cumulative innovation," Scientometrics, Springer;Akadémiai Kiadó, vol. 90(2), pages 581-606, February.
- L. Kamran Bilir, 2014. "Patent Laws, Product Life-Cycle Lengths, and Multinational Activity," American Economic Review, American Economic Association, vol. 104(7), pages 1979-2013, July.
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016.
"Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry,"
RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Bessen, James, 2009. "Estimates of patent rents from firm market value," Research Policy, Elsevier, vol. 38(10), pages 1604-1616, December.
- Wagner, Stefan & Wakeman, Simon, 2016.
"What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry,"
Research Policy, Elsevier, vol. 45(5), pages 1091-1102.
- Stefan Wagner & Simon Wakeman, 2014. "What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry," ESMT Research Working Papers ESMT-14-01 (R1), ESMT European School of Management and Technology, revised 09 Mar 2015.
- Nagaoka, Sadao & Motohashi, Kazuyuki & Goto, Akira, 2010. "Patent Statistics as an Innovation Indicator," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 2, chapter 0, pages 1083-1127, Elsevier.
- Iain M. Cockburn & Megan J. MacGarvie, 2011.
"Entry and Patenting in the Software Industry,"
Management Science, INFORMS, vol. 57(5), pages 915-933, May.
- Iain M. Cockburn & Megan J. MacGarvie, 2006. "Entry and Patenting in the Software Industry," NBER Working Papers 12563, National Bureau of Economic Research, Inc.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John Van Reenen, 2016.
"Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry,"
Journal of Political Economy, University of Chicago Press, vol. 124(1), pages 1-51.
- Philippe Aghion & Antoine Dechezlepr�tre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," GRI Working Papers 102, Grantham Research Institute on Climate Change and the Environment.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," Post-Print halshs-01496920, HAL.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," Climate Change and Sustainable Development 143129, Fondazione Eni Enrico Mattei (FEEM).
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," Working Papers 2012.99, Fondazione Eni Enrico Mattei.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2012. "Carbon taxes, path dependency and directed technical change: evidence from the auto industry," LSE Research Online Documents on Economics 48936, London School of Economics and Political Science, LSE Library.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," NBER Working Papers 18596, National Bureau of Economic Research, Inc.
- Philippe Aghion & Antoine Dechezleprêtre & David Hémous & Ralf Martin & John van Reenen, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," PSE-Ecole d'économie de Paris (Postprint) halshs-01496920, HAL.
- Aghion, Philippe & Dechezlepretre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016. "Carbon taxes, path dependency and directed technical change: evidence from the auto industry," LSE Research Online Documents on Economics 62722, London School of Economics and Political Science, LSE Library.
- Aghion, Philippe & Van Reenen, John & Martin, Ralf & Hémous, David & Dechezleprêtre, Antoine, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," CEPR Discussion Papers 9267, C.E.P.R. Discussion Papers.
- Aghion, Philippe & Dechezleprêtre, Antoine & Hemous, David & Martin, Ralf & Van Reenen, John, 2016. "Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry," Scholarly Articles 27759048, Harvard University Department of Economics.
- Philippe Aghion & Antoine Dechezleprêtre & David Hemous & Ralf Martin & John Van Reenen, 2012. "Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry," CEP Discussion Papers dp1178, Centre for Economic Performance, LSE.
- Bernhard Ganglmair & Imke Reimers, 2019.
"Visibility of Technology and Cumulative Innovation: Evidence from Trade Secrets Laws,"
CRC TR 224 Discussion Paper Series
crctr224_2019_119v1, University of Bonn and University of Mannheim, Germany.
- Bernhard Ganglmair & Imke Reimers, 2021. "Visibility of Technology and Cumulative Innovation: Evidence From Trade Secrets Laws," CRC TR 224 Discussion Paper Series crctr224_2021_119v2, University of Bonn and University of Mannheim, Germany.
- Ganglmair, Bernhard & Reimers, Imke, 2019. "Visibility of technology and cumulative innovation: Evidence from trade secrets laws," ZEW Discussion Papers 19-035, ZEW - Leibniz Centre for European Economic Research.
- Yi Deng, 2003.
"A Dynamic Stochastic Analysis of International Patent Application and Renewal Processes,"
Computing in Economics and Finance 2003
189, Society for Computational Economics.
- Deng, Yi, 2005. "A Dynamic Stochastic Analysis of International Patent Application and Renewal Processes," Departmental Working Papers 0515, Southern Methodist University, Department of Economics.
- Yi Deng, 2004. "A Dynamic Stochastic Ananlysis of International Patent Application and Renewal Processes," Econometric Society 2004 North American Summer Meetings 389, Econometric Society.
- Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
- Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:empleg:v:8:y:2011:i:4:p:613-649. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1740-1461 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.